Natural killer cell surveillance of intracellular antigen processing pathways mediated by recognition of HLA-E and Qa-1b by CD94/NKG2 receptors.

Natural killer cell surveillance of intracellular antigen processing pathways mediated by recognition of HLA-E and Qa-1b by CD94/NKG2 receptors.

HLA-E binds specifically to MHC class Ia leader peptides in a TAP (transporter associated with antigen processing)-dependent manner. It interacts with CD94/NKG2A receptors on natural killer cells and this inhibits natural killer cell lysis of the cell displaying HLA-E. The crystal structure of HLA-E...

Descrizione completa

Dettagli Bibliografici
Autore principale:	O'Callaghan, C
Natura:	Journal article
Lingua:	English
Pubblicazione:	2000

Documenti analoghi

HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C.
di: Braud, V, et al.
Pubblicazione: (1998)

A herpesvirus encoded Qa-1 mimic inhibits natural killer cell cytotoxicity through CD94/NKG2A receptor engagement
di: Xiaoli Wang, et al.
Pubblicazione: (2018-12-01)

CD94/NKG2 is the predominant inhibitory receptor involved in recognition of HLA-G by decidual and peripheral blood NK cells.
di: Söderström, K, et al.
Pubblicazione: (1997)

HLA-E is expressed on trophoblast and interacts with CD94/NKG2 receptors on decidual NK cells.
di: King, A, et al.
Pubblicazione: (2000)

Targeting LAG‐3 restores CD8+ T cell effector function through CD94/NKG2‐Qa‐1b signaling
di: Zhiqiang Wang, et al.
Pubblicazione: (2024-12-01)

A signal peptide derived from hsp60 binds HLA-E and interferes with CD94/NKG2A recognition.
di: Michaëlsson, J, et al.
Pubblicazione: (2002)

Molecular basis of human natural killer cell recognition of HLA-E (human leucocyte antigen-E) and its relevance to clearance of pathogen-infected and tumour cells.
di: O'Callaghan, C
Pubblicazione: (2000)

Regulation of NK cell functions through interaction of the CD94/NKG2 receptors with the nonclassical class I molecule HLA-E.
di: Braud, V, et al.
Pubblicazione: (1999)

Regulation of ligands for the activating receptor NKG2D.
di: Mistry, A, et al.
Pubblicazione: (2007)

NKG2D
di: O'Callaghan, C
Pubblicazione: (2009)

Activating and inhibitory receptors on synovial fluid natural killer cells of arthritis patients: role of CD94/NKG2A in control of cytokine secretion.
di: de Matos, C, et al.
Pubblicazione: (2007)

Enriched HLA-E and CD94/NKG2A interaction limits antitumor CD8+ tumor-infiltrating T lymphocyte responses
di: Abd Hamid, M, et al.
Pubblicazione: (2019)

Structural and energetic aspects of multispecific immune recognition by NKG2D.
di: O'Callaghan, C, et al.
Pubblicazione: (2003)

HLA class I signal peptide polymorphism determines the level of CD94/NKG2–HLA-E-mediated regulation of effector cell responses
di: Lin, Z, et al.
Pubblicazione: (2023)

Enriched HLA-E and CD94/NKG2a interaction limits anti-tumor CD8+ tumor-infiltrating T lymphocyte responses
di: Abd Hamid, M, et al.
Pubblicazione: (2019)

Immune checkpoints HLA-E:CD94-NKG2A and HLA-C:KIR2DL1 complementarily shield circulating tumor cells from NK-mediated immune surveillance
di: Xiaowei Liu, et al.
Pubblicazione: (2024-02-01)

A Conserved HIV-1-Derived Peptide Presented by HLA-E Renders Infected T-cells Highly Susceptible to Attack by NKG2A/CD94-Bearing Natural Killer Cells.
di: Zachary B Davis, et al.
Pubblicazione: (2016-02-01)

Balance between activating NKG2D, DNAM-1, NKp44 and NKp46 and inhibitory CD94/NKG2A receptors determine natural killer degranulation towards rheumatoid arthritis synovial fibroblasts.
di: Nielsen, N, et al.
Pubblicazione: (2014)

High-throughput characterization of HLA-E-presented CD94/NKG2x ligands reveals peptides which modulate NK cell activation
di: Huisman, BD, et al.
Pubblicazione: (2023)

High-throughput characterization of HLA-E-presented CD94/NKG2x ligands reveals peptides which modulate NK cell activation
di: Brooke D. Huisman, et al.
Pubblicazione: (2023-08-01)

CRISPR/Cas9 editing of NKG2A improves the efficacy of primary CD33-directed chimeric antigen receptor natural killer cells
di: Tobias Bexte, et al.
Pubblicazione: (2024-09-01)

Atypical natural killer T-cell receptor recognition of CD1d–lipid antigens
di: Jérôme Le Nours, et al.
Pubblicazione: (2016-02-01)

CD94-driven in vitro expansion of highly functional adaptive NKG2C+ NKG2A- CD57+ NK cells from CMV+ healthy donors
di: Chiara Giordano, et al.
Pubblicazione: (2025-01-01)

Development and function of CD94-deficient natural killer cells.
di: Mark T Orr, et al.
Pubblicazione: (2010-12-01)

Publisher Correction: High-throughput characterization of HLA-E-presented CD94/NKG2x ligands reveals peptides which modulate NK cell activation
di: Brooke D. Huisman, et al.
Pubblicazione: (2023-08-01)

Differential expression of NK receptors CD94 and NKG2A by T cells in rheumatoid arthritis patients in remission compared to active disease.
di: Ceara E Walsh, et al.
Pubblicazione: (2011-01-01)

Engaging natural killer cells for cancer therapy via NKG2D, CD16A and other receptors
di: Kerry A. Whalen, et al.
Pubblicazione: (2023-12-01)

What a Difference an Amino Acid Makes: An All-Atom Simulation Study of Nonameric Peptides in Inhibitory HLA-E/NKG2A/CD94 Immune Complexes
di: Eva Prašnikar, et al.
Pubblicazione: (2022-08-01)

Cellular metabolism controls NKG2D-dependent cellular immunogenicity
di: McCarthy, M, et al.
Pubblicazione: (2013)

Elusive Role of the CD94/NKG2C NK Cell Receptor in the Response to Cytomegalovirus: Novel Experimental Observations in a Reporter Cell System
di: Aldi Pupuleku, et al.
Pubblicazione: (2017-10-01)

Molecular competition for NKG2D: H60 and RAE1 compete unequally for NKG2D with dominance of H60.
di: O'Callaghan, C, et al.
Pubblicazione: (2001)

P1425: ACTIVATED AND EXPANDED NATURAL KILLER CELLS TRANSDUCED WITH AN NKG2D CHIMERIC ANTIGEN RECEPTOR AGAINST ACUTE MYELOID LEUKEMIA
di: L. Córdoba, et al.
Pubblicazione: (2022-06-01)

Human microRNA-1245 down-regulates the NKG2D receptor in natural killer cells and impairs NKG2D-mediated functions
di: J. Luis Espinoza, et al.
Pubblicazione: (2012-09-01)

The MHC-E peptide ligands for checkpoint CD94/NKG2A are governed by inflammatory signals, whereas LILRB1/2 receptors are peptide indifferent
di: Jim Middelburg, et al.
Pubblicazione: (2023-12-01)

Investigation of HLA-E intracellular transport and antigen presentation
di: He, W
Pubblicazione: (2023)

502 Discovery of HX017, a novel NKG2A/CD94 mAb, for potential cancer immunotherapy
di: Faming Zhang, et al.
Pubblicazione: (2023-11-01)

High-Density of FcγRIIIA+ (CD16+) Tumor-Associated Neutrophils in Metastases Improves the Therapeutic Response of Cetuximab in Metastatic Colorectal Cancer Patients, Independently of the HLA-E/CD94-NKG2A Axis
di: Marie Denis Musquer, et al.
Pubblicazione: (2021-06-01)

BLOCKING THE INHIBITORY CD94/NKG2A NK CELL RECEPTOR WITH A NOVEL ANTI-NKG2A MAB ENHANCES THE SUSCEPTIBILITY OF RHEUMATOID ARTHRITIS FIBROBLAST-LIKE SYNOVIOCYTES (FLS) TO NK CELL-MEDIATED CYTOTOXICITY
di: Nielsen, N, et al.
Pubblicazione: (2012)

Human Leucocyte Antigen-G (HLA-G) and Its Murine Functional Homolog Qa2 in the Trypanosoma cruzi Infection
di: Fabrício C. Dias, et al.
Pubblicazione: (2015-01-01)

Expression and Clinical Significance of CD8+Natural Killer T Cell Stimulatory Receptor NKG2D in Peripheral Blood of Lung Cancer Patients
di: Ni CHENG, et al.
Pubblicazione: (2010-10-01)